CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Top player positioning
3.4.Porters five force analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of arthritis
3.5.1.2.Growth in geriatric population
3.5.1.3.High demand for topical pain relief products by sportsperson
3.5.1.4.Lesser side effects caused by topical pain relief products as
compared to oral medicines

3.5.2.Restraints

3.5.2.1.Topical pain relief sometimes cause skin irritants
3.5.2.2.Topical pain relief is characterized by unpleasant odor

3.5.3.Opportunities

3.5.3.1.Emergence of online pharmacy
3.5.3.2.Opportunities in emerging economies

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on global topical pain relief market

CHAPTER 4:GLOBAL TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC
CLASS

4.1.Overview

4.1.1.Market size and forecast

4.2.Non-opioids

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by type
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.2.4.1.Nonsteroidal anti-inflammatory drugs (NSAIDS)
4.2.4.2.Methyl salicylates
4.2.4.3.Capsaicin
4.2.4.4.Lidocaine
4.2.4.5.Other non-opioids

4.3.Opioids

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by type
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.3.4.1.Buprenorphine
4.3.4.2.Fentanyl

CHAPTER 5:GLOBAL TOPICAL PAIN RELIEF MARKET, BY FORMULATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Cream

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Gel

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Spray

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Patch

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Others

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

CHAPTER 6:GLOABL. TOPICAL PAIN RELIEF MARKET, BY TYPE

6.1.Overview

6.1.1.Market size and forecast

6.2.Prescription pain relief

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Over-the-counter pain relief

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

CHAPTER 7:GLOBAL TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL

7.1.Overview

7.1.1.Market size and forecast

7.2.Pharmacies & drug stores

7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country

7.3.E-Commerce

7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country

7.4.Retail & grocery stores

7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country

CHAPTER 8:TOPICAL PAIN RELIEF MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors and opportunities
8.2.2.North America topical pain relief market, by country

8.2.2.1.U.S. topical pain relief market, by therapeutic class
8.2.2.2.U.S. topical pain relief market, by formulation
8.2.2.3.U.S. topical pain relief market, by type
8.2.2.4.U.S. topical pain relief market, by distribution channel
8.2.2.5.Canada topical pain relief market, by therapeutic class
8.2.2.6.Canada topical pain relief market, by formulation
8.2.2.7.Canada topical pain relief market, by type
8.2.2.8.Canada topical pain relief market, by distribution channel
8.2.2.9.Mexico topical pain relief market, by therapeutic class
8.2.2.10.Mexico topical pain relief market, by formulation
8.2.2.11.Mexico topical pain relief market, by type
8.2.2.12.Mexico topical pain relief market, by distribution channel

8.2.3.North America market size and forecast, by therapeutic class
8.2.4.North America market size and forecast, by formulation
8.2.5.North America market size and forecast, by type
8.2.6.North America market size and forecast, by distribution channel

8.3.Europe

8.3.1.Key market trends, growth factors and opportunities
8.3.2.Europe market size and forecast, by country

8.3.2.1.Germany topical pain relief market, by therapeutic class
8.3.2.2.Germany topical pain relief market, by formulation
8.3.2.3.Germany topical pain relief market, by type
8.3.2.4.Germany topical pain relief market, by distribution channel
8.3.2.5.France topical pain relief market, by therapeutic class
8.3.2.6.France topical pain relief market, by formulation
8.3.2.7.France topical pain relief market, by type
8.3.2.8.France topical pain relief market, by distribution channel
8.3.2.9.UK topical pain relief market, by therapeutic class
8.3.2.10.U.K. topical pain relief market, by formulation
8.3.2.11.UK topical pain relief market, by type
8.3.2.12.UK topical pain relief market, by distribution channel
8.3.2.13.Italy topical pain relief market, by therapeutic class
8.3.2.14.Italy topical pain relief market, by formulation
8.3.2.15.Italy topical pain relief market, by type
8.3.2.16.Italy topical pain relief market, by distribution channel
8.3.2.17.Spain topical pain relief market, by therapeutic class
8.3.2.18.Spain topical pain relief market, by formulation
8.3.2.19.Spain topical pain relief market, by type
8.3.2.20.Spain topical pain relief market, by distribution channel
8.3.2.21.Rest of Europe topical pain relief market, by therapeutic class
8.3.2.22.Rest of Europe topical pain relief market, by formulation
8.3.2.23.Rest of Europe topical pain relief market, by type
8.3.2.24.Rest of Europe topical pain relief market, by distribution channel

8.3.3.Europe market size and forecast, by therapeutic class
8.3.4.Europe market size and forecast, by formulation
8.3.5.Europe market size and forecast, by type
8.3.6.Europe market size and forecast, by distribution channel

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors and opportunities
8.4.2.Asia-Pacific market size and forecast, by country

8.4.2.1.China topical pain relief market, by therapeutic class
8.4.2.2.China topical pain relief market, by formulation
8.4.2.3.China topical pain relief market, by type
8.4.2.4.China topical pain relief market, by distribution channel
8.4.2.5.Japan topical pain relief market, by therapeutic class
8.4.2.6.Japan topical pain relief market, by formulation
8.4.2.7.Japan topical pain relief market, by type
8.4.2.8.Japan topical pain relief market, by distribution channel
8.4.2.9.India topical pain relief market, by therapeutic class
8.4.2.10.India topical pain relief market, by formulation
8.4.2.11.India topical pain relief market, by type
8.4.2.12.India topical pain relief market, by distribution channel
8.4.2.13.Australia topical pain relief market, by therapeutic class
8.4.2.14.Australia topical pain relief market, by formulation
8.4.2.15.Australia topical pain relief market, by type
8.4.2.16.Australia topical pain relief market, by distribution channel
8.4.2.17.South Korea topical pain relief market, by therapeutic class
8.4.2.18.South Korea topical pain relief market, by formulation
8.4.2.19.South Korea topical pain relief market, by type
8.4.2.20.South Korea topical pain relief market, by distribution channel
8.4.2.21.Rest of Asia-Pacific topical pain relief market, by therapeutic class
8.4.2.22.Rest of Asia-Pacific topical pain relief market, by formulation
8.4.2.23.Rest of Asia- Pacific topical pain relief market, by type
8.4.2.24.Rest of Asia- Pacific topical pain relief market,
by distribution channel

8.4.3.Asia-Pacific market size and forecast, by therapeutic class
8.4.4.Asia-Pacific market size and forecast, by formulation
8.4.5.Asia-Pacific market size and forecast, by type
8.4.6.Asia-Pacific market size and forecast, by distribution channel

8.5.LAMEA

8.5.1.Key market trends, growth factors and opportunities
8.5.2.LAMEA market size and forecast, by country

8.5.2.1.Brazil topical pain relief market, by therapeutic class
8.5.2.2.Brazil topical pain relief market, by formulation
8.5.2.3.Brazil topical pain relief market, by type
8.5.2.4.Brazil topical pain relief market, by distribution channel
8.5.2.5.Saudi Arabia topical pain relief market, by therapeutic class
8.5.2.6.Saudi Arabia topical pain relief market, by formulation
8.5.2.7.Saudi Arabia topical pain relief market, by type
8.5.2.8.Saudi Arabia topical pain relief market, by distribution channel
8.5.2.9.South Africa topical pain relief market, by therapeutic class
8.5.2.10.South Africa topical pain relief market, by formulation
8.5.2.11.South Africa topical pain relief market, by type
8.5.2.12.South Africa topical pain relief market, by distribution channel
8.5.2.13.Rest of LAMEA topical pain relief market, by therapeutic class
8.5.2.14.Rest of LAMEA South Africa topical pain relief market, by formulation
8.5.2.15.Rest of LAMEA topical pain relief market, by type
8.5.2.16.Rest of LAMEA topical pain relief market, by distribution channel

8.5.3.LAMEA market size and forecast, by therapeutic class
8.5.4.LAMEA market size and forecast, by formulation
8.5.5.LAMEA market size and forecast, by type
8.5.6.LAMEA market size and forecast, by distribution channel

CHAPTER 9:COMPANY PROFILES

9.1.ADVACARE PHARMA

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product Portfolio

9.2.GLAXOSMITHKLINE PLC (GSK)

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.JOHNSON & JOHNSON

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance

9.4.NESTL S.A.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product Portfolio
9.4.5.Business performance

9.5.NOVARTIS AG

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance

9.6.PFIZER INC.

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance

9.7.RECKITT BENCKISER GROUP PLC

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product Portfolio
9.7.5.Business performance

9.8.SANOFI

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance

9.9.SUN PHARMACEUTICAL INDUSTRIES LTD.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance

9.10.TOPICAL BIOMEDICS, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product Portfolio